Stock Traders Purchase Large Volume of Put Options on Danaher (NYSE:DHR)

Danaher Corporation (NYSE:DHR) was the recipient of some unusual options trading activity on Thursday. Stock investors bought 24,187 put options on the stock. This is an increase of 308% compared to the average daily volume of 5,928 put options.

Institutional Investors Weigh In On Danaher

Several institutional investors have recently modified their holdings of the business. Bank Pictet & Cie Europe AG lifted its stake in shares of Danaher by 25.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after purchasing an additional 74,301 shares during the last quarter. Defender Capital LLC. bought a new stake in Danaher during the fourth quarter valued at about $35,715,000. Northwestern Mutual Wealth Management Co. grew its stake in Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares during the last quarter. Peak Financial Advisors LLC grew its stake in Danaher by 215.4% in the fourth quarter. Peak Financial Advisors LLC now owns 10,638 shares of the conglomerate’s stock valued at $2,435,000 after purchasing an additional 7,265 shares during the last quarter. Finally, SeaBridge Investment Advisors LLC bought a new position in Danaher in the fourth quarter worth about $4,477,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of DHR opened at $192.52 on Friday. Danaher has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm’s 50-day simple moving average is $185.05 and its two-hundred day simple moving average is $197.07. The stock has a market cap of $135.34 billion, a PE ratio of 34.20, a price-to-earnings-growth ratio of 2.19 and a beta of 0.79. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.65.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 earnings per share. Analysts anticipate that Danaher will post 8.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s dividend payout ratio is 30.95%.

Danaher News Summary

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Several commentary pieces say the post-earnings drop may have created a buying opportunity, with Barron’s arguing investors should not abandon Danaher (DHR) after the sharp reaction and suggesting the stock could rebound. Article: Don’t Quit on Danaher Stock After Horrific Earnings Reaction
• Positive Sentiment: One technical-market update said the selloff may be showing signs of capitulation, and noted some bullish trading activity in the shares, which could indicate downside pressure is easing. Article: Stock Of The Day: Is The Danaher Selloff Over?
• Positive Sentiment: Wall Street analysts still see meaningful upside from current levels, with one note highlighting a consensus price target implying about 32% potential gain and improving earnings estimate revisions. Article: Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?
• Neutral Sentiment: Danaher’s Q2 2026 earnings call transcript was published, giving investors a fresh look at management’s commentary and the company’s outlook, but the transcript itself does not change fundamentals. Article: Danaher (DHR) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Unusual options activity showed elevated put buying in Danaher (DHR), suggesting some traders are hedging for further downside or volatility after the earnings-driven move.
• Negative Sentiment: Recent coverage says the stock’s sharp decline was driven by Q2 results where a beat on earnings was overshadowed by bioprocessing weakness and analyst price-target cuts, which remain the main bearish overhang on the shares. Article: Stock Of The Day: Is The Danaher Selloff Over?

Analyst Upgrades and Downgrades

DHR has been the topic of several recent analyst reports. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. HSBC lowered their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. TD Cowen cut their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday. Finally, Wells Fargo & Company decreased their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.